Sort   by:  
 Page size 
TranscriptomicsIdentification of differentially expressed genes upon treatment with Eltrombopag in HL60 cells
Identification of differentially expressed genes upon treatment with Eltrombopag in HL60 cells. HL60 cells were untreated, or treated with 3ug/ml of Eltrombopag for 36 hrs in RPMI with 10% FBS HL60 cells were untreated, or treated with 3ug/ml of Eltrombopag for 36 hrs in RPMI with 10% FBS
ORGANISM(S): Homo sapiens 
2012-06-24 | E-GEOD-37580 | biostudies-arrayexpress
GenomicsGene expression profiling of mouse HSCs treated with Eltrombopag
Gene expression profiling of mouse HSCs treated with Eltrombopag
PRJNA420065 | ENA
GenomicsGene expression profiling of human HSCs treated with Eltrombopag
Gene expression profiling of human HSCs treated with Eltrombopag
PRJNA420066 | ENA
TranscriptomicsGene expression profiling of human HSCs treated with Eltrombopag
Eltrombopag, a small molecule thrombopoietin receptor (TPO-R) agonist and potent intracellular iron chelator, has shown remarkable efficacy to stimulate sustained multilineage hematopoiesis in patients with bone marrow failure syndromes, suggesting an effect at the most immature hematopoietic stem a...
ORGANISM(S): Homo sapiens 
2018-09-17 | GSE107428 | GEO
TranscriptomicsGene expression profiling of mouse HSCs treated with Eltrombopag
Eltrombopag, a small molecule thrombopoietin receptor (TPO-R) agonist and potent intracellular iron chelator, has shown remarkable efficacy to stimulate sustained multilineage hematopoiesis in patients with bone marrow failure syndromes, suggesting an effect at the most immature hematopoietic stem a...
ORGANISM(S): Mus musculus 
2018-09-17 | GSE107429 | GEO
TranscriptomicsIdentification of differentially expressed genes upon treatment with Eltrombopag in HL60 cells
Identification of differentially expressed genes upon treatment with Eltrombopag in HL60 cells. HL60 cells were untreated, or treated with 3ug/ml of Eltrombopag for 36 hrs in RPMI with 10% FBS
ORGANISM(S): Homo sapiens 
2012-06-25 | GSE37580 | GEO
TranscriptomicsRNA sequencing of Cryptococcus neoformans H99 treated with eltrombopag
The gene expression of C. neoformans H99 treated with eltrombopag
ORGANISM(S): Cryptococcus neoformans H99 
2018-06-12 | GSE115570 | GEO
GenomicsRNA sequencing of Cryptococcus neoformans H99 treated with eltrombopag
RNA sequencing of Cryptococcus neoformans H99 treated with eltrombopag
PRJNA475496 | ENA
GenomicsTranscriptomic profiling of Candida glabrata under eltrombopag (ETP) treatment
Transcriptomic profiling of Candida glabrata under eltrombopag (ETP) treatment
PRJNA1471188 | ENA
TranscriptomicsBlood transcriptome and clonal T cell correlates of response and nonresponse to eltrombopag therapy in a cohort of patients with chronic immune thrombocytopenia
We evaluated the longitudinal effect of eltrombopag, a thrombopoietin receptor agonist, on gene expression in heavily pretreated patients with chronic immune thrombocytopenia (ITP) using blood transcriptome analysis on pretreatment, and following 1 week and 1 month of treatment samples. A strong sti...
ORGANISM(S): Homo sapiens 
2021-03-21 | GSE112278 | GEO
Sort   by:  
 Page size